In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Carisma Therapeutics Inc (NASDAQ: CARM) was $1.11 for the day, up 389.42% from the previous closing price of $0.23. In other words, the price has increased by $389.42 from its previous closing price. On the day, 692.32 million shares were traded.
Ratios:
Our analysis of CARM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on December 12, 2024, Downgraded its rating to Neutral and sets its target price to $1 from $10 previously.
On April 11, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 11, 2024, with a $6 target price.
Stock Price History:
Over the past 52 weeks, CARM has reached a high of $1.90, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 405.06%, while the 200-Day Moving Average is calculated to be 88.30%.
Shares Statistics:
A total of 41.79M shares are outstanding, with a floating share count of 21.12M. Insiders hold about 49.46% of the company’s shares, while institutions hold 8.10% stake in the company.
